Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
A web-based self-management program for people with type 2 diabetes was more cost effective than usual care, according to a survey published June 8 in the Journal of Medical Internet Research.
Internet-based interventions designed to support family caregivers of patients with dementia improved stress and anxiety, according to a study published June 12 in the Journal of Medical Internet Research.
Nearly three-fourths of life science professionals believe their sector is behind others in the development of artificial intelligence (AI), according to a survey conducted by the Pistoia Alliance.
Researchers from Brigham and Women's Hospital in Boston have developed “surgery in a pill” to treat type 2 diabetes by lowering blood glucose levels after a meal. The newly developed approach was outlined in a study published June 11 in Nature Materials.
Between 2008 and 2016, NPs increased from 17.6 percent of providers in rural areas to 25.2 percent. In non-rural areas, the increase was smaller but still significant—with the share of NPs making up 23 percent of the providers in 2016, up from 15.9 percent in 2008.
It stands to reason oversight from an experienced colleague could help reduce mistakes from greener individuals. But increased supervision of medical residents by attending physicians during patient rounds did not significantly reduce the number of medical errors, according to a study published June 4 in JAMA Internal Medicine.
Nearly three quarters of infection preventionists (IP) had single-site responsibilities and dedicated more than 75 percent of their time to prevention and control, according to a study published May 31 in the American Journal of Infection Control.
